Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor‐independent mechanism

Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor‐independent... We evaluated the ability of cannabidiol (CBD) to impair the migration of tumor cells stimulated by conditioned medium. CBD caused concentration‐dependent inhibition of the migration of U87 glioma cells, quantified in a Boyden chamber. Since these cells express both cannabinoid CB1 and CB2 receptors in the membrane, we also evaluated their engagement in the antimigratory effect of CBD. The inhibition of cell was not antagonized either by the selective cannabinoid receptor antagonists SR141716 (CB1) and SR144528 (CB2) or by pretreatment with pertussis toxin, indicating no involvement of classical cannabinoid receptors and/or receptors coupled to Gi/o proteins. These results reinforce the evidence of antitumoral properties of CBD, demonstrating its ability to limit tumor invasion, although the mechanism of its pharmacological effects remains to be clarified. British Journal of Pharmacology (2005) 144, 1032–1036. doi:10.1038/sj.bjp.0706134 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png British Journal of Pharmacology Wiley

Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor‐independent mechanism

Download PDF
5 pages

Loading next page...
 
/lp/wiley/cannabidiol-inhibits-human-glioma-cell-migration-through-a-cannabinoid-gR0oEi08du
Publisher
Wiley
Copyright
2005 British Pharmacological Society
ISSN
0007-1188
eISSN
1476-5381
DOI
10.1038/sj.bjp.0706134
pmid
15700028
Publisher site
See Article on Publisher Site

Abstract

We evaluated the ability of cannabidiol (CBD) to impair the migration of tumor cells stimulated by conditioned medium. CBD caused concentration‐dependent inhibition of the migration of U87 glioma cells, quantified in a Boyden chamber. Since these cells express both cannabinoid CB1 and CB2 receptors in the membrane, we also evaluated their engagement in the antimigratory effect of CBD. The inhibition of cell was not antagonized either by the selective cannabinoid receptor antagonists SR141716 (CB1) and SR144528 (CB2) or by pretreatment with pertussis toxin, indicating no involvement of classical cannabinoid receptors and/or receptors coupled to Gi/o proteins. These results reinforce the evidence of antitumoral properties of CBD, demonstrating its ability to limit tumor invasion, although the mechanism of its pharmacological effects remains to be clarified. British Journal of Pharmacology (2005) 144, 1032–1036. doi:10.1038/sj.bjp.0706134

Journal

British Journal of Pharmacology – Wiley

Published: Apr 1, 2005

References

  • Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide
    BISOGNO, BISOGNO; HANUS, HANUS; PETROCELLIS, PETROCELLIS; TCHILIBON, TCHILIBON; PONDE, PONDE; BRANDI, BRANDI; MORIELLO, MORIELLO; DAVIS, DAVIS; MECHOULAM, MECHOULAM; DI MARZO, DI MARZO
  • Differential expression of the CB2 cannabinoid receptor by rodent macrophages and macrophage‐like cells in relation to cell activation
    CARLISLE, CARLISLE; MARCIANO‐CABRAL, MARCIANO‐CABRAL; STAAB, STAAB; LUDWICK, LUDWICK; CABRAL, CABRAL
  • Cannabinoids: potential anticancer agents
    GUZMAN, GUZMAN
  • International Union of Pharmacology. XXVII. Classification of cannabinoid receptors
    HOWLETT, HOWLETT; BARTH, BARTH; BONNER, BONNER; CABRAL, CABRAL; CASELLAS, CASELLAS; DEVANE, DEVANE; FELDER, FELDER; HERKENHAM, HERKENHAM; MACKIE, MACKIE; MARTIN, MARTIN; MECHOULAM, MECHOULAM; PERTWEE, PERTWEE
  • Cannabinoid‐induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors
    JARAI, JARAI; WAGNER, WAGNER; VARGA, VARGA; LAKE, LAKE; COMPTON, COMPTON; MARTIN, MARTIN; ZIMMER, ZIMMER; BONNER, BONNER; BUCKLEY, BUCKLEY; MEZEY, MEZEY; RAZDAN, RAZDAN; ZIMMER, ZIMMER; KUNOS, KUNOS
  • Hematopoietic cells expressing the peripheral cannabinoid receptor migrate in response to the endocannabinoid 2‐arachidonoylglycerol
    JORDÀ, JORDÀ; VERBAKEL, VERBAKEL; VALK, VALK; VANKAN‐BERKHOUDT, VANKAN‐BERKHOUDT; MACCARRONE, MACCARRONE; FINAZZI‐AGRO, FINAZZI‐AGRO; LOWENBERG, LOWENBERG; DELWEL, DELWEL
  • Anandamide is an endogenous inhibitor for the migration of tumor cells and T lymphocytes
    JOSEPH, JOSEPH; NIGGEMANN, NIGGEMANN; ZAENKER, ZAENKER; ENTSCHLADEN, ENTSCHLADEN
  • 2‐Arachidonoylglycerol induces the migration of HL‐60 cells differentiated into macrophage‐like cells and human peripheral blood monocytes through the cannabinoid CB2 receptor‐dependent mechanism
    KISHIMOTO, KISHIMOTO; GOKOH, GOKOH; OKA, OKA; MURAMATSU, MURAMATSU; KAJIWARA, KAJIWARA; WAKU, WAKU; SUGIURA, SUGIURA
  • Antitumor effects of cannabidiol, a nonpsychoactive cannabinoid, on human glioma cell lines
    MASSI, MASSI; VACCANI, VACCANI; CERUTI, CERUTI; COLOMBO, COLOMBO; ABBRACCHIO, ABBRACCHIO; PAROLARO, PAROLARO
  • Endocannabinoids in the immune system and cancer
    PAROLARO, PAROLARO; MASSI, MASSI; RUBINO, RUBINO; MONTI, MONTI
  • Cannabinoid receptors and their ligands
    PERTWEE, PERTWEE; ROSS, ROSS
  • Inhibitory effects of cannabinoid CB1 receptor stimulation on tumor growth and metastatic spreading: actions on signals involved in angiogenesis and metastasis
    PORTELLA, PORTELLA; LAEZZA, LAEZZA; LACCETTI, LACCETTI; PETROCELLIS, PETROCELLIS; DI MARZO, DI MARZO; BIFULCO, BIFULCO
  • Effects of delta‐9‐tetrahydrocannabinol on human immune function and host defense
    ROTH, ROTH; BALDWIN, BALDWIN; TASHKIN, TASHKIN
  • In vivo and in vitro treatment with the synthetic cannabinoid CP55, 940 decreases the in vitro migration of macrophages in the rat: involvement of both CB1 and CB2 receptors
    SACERDOTE, SACERDOTE; MASSI, MASSI; PANERAI, PANERAI; PAROLARO, PAROLARO
  • Delta9‐tetrahydrocannabinol induces apoptosis in C6 glioma cells
    SANCHEZ, SANCHEZ; GALVE‐ROPERH, GALVE‐ROPERH; CANOVA, CANOVA; BRACHET, BRACHET; GUZMAN, GUZMAN
  • Rat brain cannabinoid receptors are N‐linked glycosylated proteins
    SONG, SONG; HOWLETT, HOWLETT
  • Nonpsychotropic cannabinoid receptors regulate microglial cell migration
    WALTER, WALTER; FRANKLIN, FRANKLIN; WITTING, WITTING; WADE, WADE; XIE, XIE; KUNOS, KUNOS; MACKIE, MACKIE; STELLA, STELLA